MedPath

Chinese Osteoporotic Fracture Registration Network Platform

Completed
Conditions
Osteoporotic Fractures
Osteoporosis
Interventions
Other: No additional intervention will be administered.
Registration Number
NCT05339425
Lead Sponsor
Peking Union Medical College Hospital
Brief Summary

China has gradually entered an aging society, and the incidence of osteoporotic fractures is increasing rapidly. Although the harm of osteoporotic fracture is huge, its diagnostic rate in China is still low. China still lacks a national osteoporotic fracture registration system, which has been established in many countries. The purpose of this study is to establish a Chinese osteoporotic fracture registration network platform (CORN), which will be helpful for the long-term comprehensive management of osteoporotic fracture population in China. This platform will help to establish a large prospective clinical cohort database of osteoporotic fractures and high-risk population in China.

Detailed Description

Previous studies have shown that the screening, diagnosis and treatment rates of osteoporosis and osteoporotic fracture in China are still low. The goal of this study is to establish a nationwide multicenter osteoporotic fracture registration network platform, a national collaborative network, a large osteoporotic fracture research cohort and a national biological specimen bank in Chinese mainland.

About 100 hospitals covering 20 provinces, autonomous regions and municipalities will be selected as collaborators. Each collaborator is going to enroll at least 500 patients with osteoporotic fractures on average, and a total of 50000 subjects are planned to be enrolled in our study.

Subjects will be assessed as follows:

1. Questionnaire investigation: including demographic data, past medical history, reproductive history, menstrual/menopausal history, family history of osteoporosis and fractures, awareness of disease, diagnosis and treatment of osteoporotic fractures, etc.

2. Clinical features: including anthropometric data, clinical symptoms, physical examination, grip strength test, balance assessment, walking speed test, etc.

3. Fall risk assessment: assessed by the Short Physical Performance Battery (SPPB), the Falls Risk for Older People in the Community (FROP-Com) and Morse Fall Scale (MFS).

4. Imaging evaluation: including thoracolumbar spine x-ray, bone mineral density (BMD) measurement by dual-energy x-ray absorptiometry (DXA), Quantitative computed tomography (QCT) and high-resolution peripheral quantitative computed tomography (HR-pQCT).

5. Laboratory tests: including blood calcium and phosphorus levels, bone turnover markers, parathyroid hormone level, 25-hydroxyvitamin D, 24-hour urine calcium, etc.

6. Biological specimen collection: blood and urine specimens are plan to be obtained for further studies with informed consent.

7. Follow-ups: subjects will be followed up every 6 months for 3 years.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50000
Inclusion Criteria

Not provided

Exclusion Criteria
  • Patients who are unwilling to participate in the trial, have poor compliance and do not sign informed consent.
  • Patients judged as unqualified participants by clinicians.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Osteoporotic fractureNo additional intervention will be administered.No additional intervention will be administered.
Primary Outcome Measures
NameTimeMethod
Bone turnover markers (BTMs)3 years

BTMs of enrolled patients will be tested and analyzed.

Health record analysis3 years

A comprehensive evaluation of patients' medical records, including symptoms, physical examination, treatments, etc.

Fracture risk Assessment of enrolled patients3 years

Fracture risk will be assessed with Fracture Risk Assessment Tool (FRAX). And a higher value means a higher risk of fracture.

Total number of patients enrolled in 3 years3 years

The number of patients enrolled in Chinese Osteoporotic Fracture Registration Network Platform (CORN) in 3 years

Age distribution3 years

Age distribution of enrolled patients

Body Mass Index (BMI) of enrolled patients3 years

Weight and height will be combined to report BMI in kg/m\^2

Quality of life of enrolled patients3 years

Quality of life will be assessed with a five-level EuroQol five-dimensional (EQ-5D-5L) questionnaire (Chinese version). Measurement results of EQ-5D-5L will be used to generate values with an EQ-5D-5L Value Set for China. And a higher value means a better QOL.

Bone mineral density of enrolled patients3 years

Bone mineral density (BMD) should be measured with dual energy X-ray absorptiometry (DXA).

Sex ratio3 years

Sex ratio of enrolled patients

Fall risk assessment of enrolled patients3 years

Fall risk will be assessed with Morse Fall Scale (Chinese version). The minimum value is 0, and the maximum value is 125. A higher value means a higher risk of fall.

Secondary Outcome Measures
NameTimeMethod
Follow-up rate after enrollmentEvery year of the 3 years

Follow-up rate after enrollment will be calculated

Usage rate of anti-osteoporosis drugsEvery year of the 3 years

Usage rate of anti-osteoporosis drugs will be analyzed

Trial Locations

Locations (39)

Peking Union Medical College Hospital

🇨🇳

Beijing, Beijing, China

Beijing Hospital

🇨🇳

Beijing, Beijing, China

Beijing Shijingshan Hospital

🇨🇳

Beijing, Beijing, China

Peking University Third Hospital

🇨🇳

Beijing, Beijing, China

The Second Medical Center of The General Hospital of the People's Liberation Army

🇨🇳

Beijing, Beijing, China

Xuanwu Hospital, Capital Medical University

🇨🇳

Beijing, Beijing, China

Daping Hospital, Army Medical Center of PLA

🇨🇳

Chongqing, Chongqing, China

The Second Affiliated Hospital of Chongqing Medical University

🇨🇳

Chongqing, Chongqing, China

Fuzhou Second Hospital

🇨🇳

Fuzhou, Fujian, China

The First Affiliated Hospital of Fujian Medical University

🇨🇳

Fuzhou, Fujian, China

Lunjiao Hospital of Shunde Foshan

🇨🇳

Foshan, Guangdong, China

Guangdong Provincial People's Hospital

🇨🇳

Guangzhou, Guangdong, China

Nanfang Hospital, Southern Medical University

🇨🇳

Guangzhou, Guangdong, China

The First Affiliated Hospital of Guangzhou University of Chinese Medicine

🇨🇳

Guangzhou, Guangdong, China

The Second Affiliated Hospital of Guangzhou Medical University

🇨🇳

Guangzhou, Guangdong, China

Shenzhen Second People's Hospital

🇨🇳

Shenzhen, Guangdong, China

The Seventh Affiliated Hospital, Sun Yat-sen University

🇨🇳

Shenzhen, Guangdong, China

Guizhou Provincial Orthopedics Hospital

🇨🇳

Guiyang, Guizhou, China

The Third Hospital of Hebei Medical University

🇨🇳

Shijiazhuang, Hebei, China

The Second Affiliated Hospital of Harbin Medical University

🇨🇳

Harbin, Heilongjiang, China

The First Affiliated Hospital of Zhengzhou University

🇨🇳

Zhengzhou, Henan, China

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

🇨🇳

Wuhan, Hubei, China

The Second Xiangya Hospital of Central South University

🇨🇳

Changsha, Hunan, China

The First People's hospital of Changzhou

🇨🇳

Changzhou, Jiangsu, China

Affiliated Hospital of Nantong University

🇨🇳

Nantong, Jiangsu, China

Nantong First People's Hospital

🇨🇳

Nantong, Jiangsu, China

The Second Affiliated Hospital of Soochow University

🇨🇳

Suzhou, Jiangsu, China

Dalian Hospital of Chinese Traditional and Western Medicine

🇨🇳

Dalian, Liaoning, China

The First Affiliated Hospital of Xi'an Jiaotong University

🇨🇳

Xi'an, Shaanxi, China

Ruijin Hospital, Shanghai Jiaotong University School of Medicine

🇨🇳

Shanghai, Shanghai, China

Shanghai Changzheng Hospital

🇨🇳

Shanghai, Shanghai, China

Tenth People's Hospital of Tongji University

🇨🇳

Shanghai, Shanghai, China

Sichuan Province Orthopedic Hospital

🇨🇳

Chendu, Sichuan, China

Sichuan Provincial People's Hospital

🇨🇳

Chendu, Sichuan, China

West China Fourth Hospital, Sichuan University

🇨🇳

Chendu, Sichuan, China

Tianjin First Central Hospital

🇨🇳

Tianjin, Tianjin, China

Traditional Chinese Medicine Hospital of Xinjiang Uygur Autonomous Region

🇨🇳

Urumqi, Xinjiang, China

The Second Affiliated Hospital, Zhejiang University School of Medicine

🇨🇳

Hangzhou, Zhejiang, China

Huamei Hospital, University of Chinese Academy of Sciences

🇨🇳

Ningbo, Zhejiang, China

© Copyright 2025. All Rights Reserved by MedPath